OmniSeq provides tissue-based sequencing tests for late-stage solid tumors, delivering actionable tumor-profiling information to physicians and their patients. This technology enables personalized treatment decisions by identifying specific genetic alterations that can inform targeted therapies.
Funding
$2B raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Late-stage solid tumors often require comprehensive genomic profiling to identify actionable genetic alterations. Traditional methods may not always provide a complete picture of the tumor's characteristics, hindering personalized treatment decisions.
Solution
OmniSeq, a Labcorp company, offers tissue-based sequencing tests designed for late-stage solid tumors, providing physicians with comprehensive tumor-profiling information. Their OmniSeq INSIGHT assay delivers genomic and immune profiling, identifying specific genetic alterations that can inform targeted therapies and personalized treatment strategies. The company also provides expanded capacity for contract research services, including genomic and immune profiling, gene expression analysis, transcriptome sequencing, and genome/exome sequencing. These services support researchers and biopharmaceutical partners in advancing cancer research and drug development.
Target Audience
The primary customers are oncologists and other physicians treating patients with late-stage solid tumors, as well as biopharmaceutical companies and researchers involved in cancer research and drug development.
Features
- OmniSeq INSIGHT: Comprehensive genomic and immune profiling assay for solid tumors
- Identifies actionable genetic alterations to inform targeted therapies
- Contract research services: genomic and immune profiling, gene expression, TCRβ repertoire and PDL-1 IHC
- Transcriptome sequencing and genome/exome sequencing available
- Access to the OmniSeq portal to check results, adjust orders, and track specimen status